195 related articles for article (PubMed ID: 17997326)
1. Purification and biochemical characterization of ovine alpha-1-proteinase inhibitor: mechanistic adaptations and role of Phe350 and Met356.
Gupta VK; Appu Rao AG; Gowda LR
Protein Expr Purif; 2008 Feb; 57(2):290-302. PubMed ID: 17997326
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1-proteinase inhibitor is a heparin binding serpin: molecular interactions with the Lys rich cluster of helix-F domain.
Gupta VK; Gowda LR
Biochimie; 2008 May; 90(5):749-61. PubMed ID: 18261994
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of alpha 1-protease inhibitor from canine plasma.
Melgarejo T; Williams DA; Griffith G
Am J Vet Res; 1996 Mar; 57(3):258-63. PubMed ID: 8669751
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of alpha1-proteinase inhibitor from common carp (Cyprinus carpio) seminal plasma.
Wojtczak M; Całka J; Glogowski J; Ciereszko A
Comp Biochem Physiol B Biochem Mol Biol; 2007 Nov; 148(3):264-76. PubMed ID: 17681818
[TBL] [Abstract][Full Text] [Related]
5. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma.
Phadke M; Billimoria FR; Ninjoor V
J Postgrad Med; 1998; 44(2):29-34. PubMed ID: 10703566
[TBL] [Abstract][Full Text] [Related]
6. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
Sutherland JS; Bhakta V; Filion ML; Sheffield WP
Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
[TBL] [Abstract][Full Text] [Related]
7. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
8. Purification and partial characterization of feline alpha1-proteinase inhibitor (falpha1-PI) and the development and validation of a radioimmunoassay for the measurement of falpha1-PI in serum.
Fetz K; Ruaux CG; Steiner JM; Suchodolski JS; Williams DA
Biochimie; 2004 Jan; 86(1):67-75. PubMed ID: 14987802
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
10. Interactions of alpha1-proteinase inhibitor with small ligands of therapeutic potential: binding with retinoic acid.
Karnaukhova E
Amino Acids; 2010 Apr; 38(4):1011-20. PubMed ID: 19495939
[TBL] [Abstract][Full Text] [Related]
11. Opossum serum alpha 1-proteinase inhibitor: purification, linear sequence, and resistance to inactivation by rattlesnake venom metalloproteinases.
Catanese JJ; Kress LF
Biochemistry; 1993 Jan; 32(2):509-15. PubMed ID: 8422360
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of alpha-1-proteinase inhibitor from goat plasma.
Salahuddin P
Biochem Int; 1991 May; 24(2):321-38. PubMed ID: 1930250
[TBL] [Abstract][Full Text] [Related]
13. Biotinylated trypsin and its application as a sensitive, versatile probe for the detection and characterisation of an ovine chondrocyte serine proteinase inhibitor using Western blotting.
Rodgers KJ; Melrose J; Ghosh P
Electrophoresis; 1996 Jan; 17(1):213-8. PubMed ID: 8907542
[TBL] [Abstract][Full Text] [Related]
14. A Kunitz proteinase inhibitor from Archidendron ellipticum seeds: purification, characterization, and kinetic properties.
Bhattacharyya A; Mazumdar S; Leighton SM; Babu CR
Phytochemistry; 2006 Feb; 67(3):232-41. PubMed ID: 16376957
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition.
Cercek L; Cercek B
Cancer Detect Prev; 1993; 17(3):447-54. PubMed ID: 7691406
[TBL] [Abstract][Full Text] [Related]
16. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases.
Rapala-Kozik M; Potempa J; Nelson D; Kozik A; Travis J
Biol Chem; 1999 Oct; 380(10):1211-6. PubMed ID: 10595584
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of sheep alpha 1-proteinase inhibitor.
Mistry R; Snashall PD; Totty N; Guz A; Tetley TD
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):685-90. PubMed ID: 1899999
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of an irreversible serine protease inhibitor from skin secretions of Bufo andrewsi.
Zhao Y; Jin Y; Wei SS; Lee WH; Zhang Y
Toxicon; 2005 Nov; 46(6):635-40. PubMed ID: 16154609
[TBL] [Abstract][Full Text] [Related]
19. The use of immobilized methylchymotrypsin for the purification of human and sheep alpha-1-proteinase inhibitor (alpha(1)-PI).
Grybel J; Wilusz T
Cell Mol Biol Lett; 2003; 8(2):363-74. PubMed ID: 12813571
[TBL] [Abstract][Full Text] [Related]
20. Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.
Miyamoto Y; Akaike T; Alam MS; Inoue K; Hamamoto T; Ikebe N; Yoshitake J; Okamoto T; Maeda H
Biochem Biophys Res Commun; 2000 Jan; 267(3):918-23. PubMed ID: 10673391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
